Murray Brunt, Adrian
Haviland, Joanne S
Wheatley, Duncan A
Sydenham, Mark A
Alhasso, Abdulla
Bloomfield, David J
Chan, Charlie
Churn, Mark
Cleator, Susan
Coles, Charlotte E
Goodman, Andrew
Harnett, Adrian
Hopwood, Penelope
Kirby, Anna M
Kirwan, Cliona C
Morris, Carolyn
Nabi, Zohal
Sawyer, Elinor
Somaiah, Navita
Stones, Liba
Syndikus, Isabel
Bliss, Judith M
Yarnold, John R
Alhasso, Abdulla
Armstrong, Anne
Bliss, Judith
Bloomfield, David
Bowen, Jo
Brunt, Murray
Chan, Charlie
Chantler, Hannah
Churn, Mark
Cleator, Susan
Coles, Charlotte
Donovan, Ellen
Goodman, Andy
Griffin, Susan
Haviland, Jo
Hopwood, Penny
Kirby, Anna
Kirk, Julie
Kirwan, Cliona
MacLennan, Marjory
Morris, Carolyn
Nabi, Zohal
Sawyer, Elinor
Sculphur, Mark
Sinclair, Judith
Somaiah, Navita
Stones, Liba
Sydenham, Mark
Syndikus, Isabel
Tremlett, Jean
Venables, Karen
Wheatley, Duncan
Yarnold, John
Funding for this research was provided by:
Cancer Research UK (C1491/A15955, C1491/A25351)
This article is maintained by: Elsevier
Article Title: Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial
Journal Title: The Lancet
CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/S0140-6736(20)30932-6
CrossRef DOI link to the associated document: https://doi.org/10.1016/S0140-6736(20)30978-8
Content Type: article
Copyright: © 2020 The Author(s). Published by Elsevier Ltd.